A Phase 3 Study Evaluating the Efficacy and Safety of Lenalidomide (Len) Combined with Melphalan and Prednisone Followed by Continuous Lenalidomide Maintenance (MPR-R) in Patients (Pts) ≥ 65 Years (Yrs) with Newly Diagnosed Multiple Myeloma (NDMM)

Konference: 2011 53rd ASH Annual Meeting – účast ČR

Kategorie: Mnohočetný myelom

Téma: 653. Myeloma - Therapy, excluding Transplantation I

Číslo abstraktu: 475

Autoři: MD Antonio P. Palumbo; prof. MUDr. Zdeněk Adam, CSc.; MD Martin (H.) Kropff; Robert (Robin) Foa (Foà); MBBS John V. Catalano, FRACP FRCPA; MD Heinz Gisslinger; Prof. Dr. Wieslaw Wiktor-Jedrzejczak, PhD; MD Michel Delforge, PhD; MD Katja C. Weisel; MD Nicola Cascavilla; MD Jan van Droogenbroeck, PhD; MD Genadi Iosava; MD Michele Cavo; Prof. Dr. Joan Bladé, PhD; prof. MD Meral Beksac; Prof.MUDr. Ivan Špička, PhD; MD Torben Plesner; Zhinuan Yu, PhD; Lindsey Herbein; MD Jay M. Mei, PhD; Christian J. Jacques; Meletios Athanasios Dimopoulos, MD

Datum přednesení příspěvku: 12. 12. 2011